NZ182022A - Antiglaucoma compositions comprising 1-t butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy)-2-prodanol hydogen maleate - Google Patents

Antiglaucoma compositions comprising 1-t butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy)-2-prodanol hydogen maleate

Info

Publication number
NZ182022A
NZ182022A NZ182022A NZ18202276A NZ182022A NZ 182022 A NZ182022 A NZ 182022A NZ 182022 A NZ182022 A NZ 182022A NZ 18202276 A NZ18202276 A NZ 18202276A NZ 182022 A NZ182022 A NZ 182022A
Authority
NZ
New Zealand
Prior art keywords
prodanol
hydogen
thiadiazol
butylamino
yloxy
Prior art date
Application number
NZ182022A
Inventor
C Stone
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NZ182022A publication Critical patent/NZ182022A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NZ182022A 1975-09-26 1976-09-13 Antiglaucoma compositions comprising 1-t butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy)-2-prodanol hydogen maleate NZ182022A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61711875A 1975-09-26 1975-09-26

Publications (1)

Publication Number Publication Date
NZ182022A true NZ182022A (en) 1978-12-18

Family

ID=24472326

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ182022A NZ182022A (en) 1975-09-26 1976-09-13 Antiglaucoma compositions comprising 1-t butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy)-2-prodanol hydogen maleate

Country Status (12)

Country Link
AU (1) AU513280B2 (en)
BE (1) BE846574A (en)
CY (1) CY1023A (en)
GB (1) GB1524405A (en)
HK (1) HK67579A (en)
IE (1) IE44167B1 (en)
IL (1) IL50477A (en)
KE (1) KE2990A (en)
MY (1) MY8000138A (en)
NZ (1) NZ182022A (en)
PH (1) PH13467A (en)
ZA (1) ZA765752B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ192673A (en) * 1979-02-02 1984-07-06 Merck & Co Inc Ophthalmic compositions for lowering intraocular pressure
US4402976A (en) 1981-04-24 1983-09-06 E. R. Squibb & Sons, Inc. Method for treating glaucoma with systemic nadolol compositions
GB8822285D0 (en) * 1988-09-22 1988-10-26 Ddsa Pharmaceuticals Ltd Opthalmic preparations

Also Published As

Publication number Publication date
AU513280B2 (en) 1980-11-27
IL50477A0 (en) 1976-11-30
HK67579A (en) 1979-09-28
GB1524405A (en) 1978-09-13
CY1023A (en) 1980-08-01
IE44167B1 (en) 1981-08-26
AU1771476A (en) 1978-03-23
IL50477A (en) 1979-09-30
IE44167L (en) 1977-03-26
BE846574A (en) 1977-03-24
MY8000138A (en) 1980-12-31
ZA765752B (en) 1978-05-30
PH13467A (en) 1980-05-15
KE2990A (en) 1979-09-28

Similar Documents

Publication Publication Date Title
PH14219A (en) 2-phenyl-3-aroylbenzothiophenes useful as antipertility agents
JPS51150553A (en) Incombustible plastics base compositions
JPS51150560A (en) Filmmforming compositions
JPS51150561A (en) Filmmforming compositions
JPS5488958A (en) Cumyuphenol derivative composition
ZA767284B (en) Superparmagnetic wax compositions
GB1538554A (en) Hydrocurable compositions
ZA763211B (en) Analgetic compositions
AU510905B2 (en) Mannich base composition
JPS51128983A (en) 3*44dihydrospiroo2hh1*33 benzoxazines
GB1548675A (en) Odiurant compositions
GB1549326A (en) Sunprotective compositions
PH12102A (en) 2,1,3-benzothiadiazole as myotonolytics
JPS5248638A (en) Aminophenol
IL49358A0 (en) New serological albumin compositions
JPS5250320A (en) Gelain compositions
JPS5272706A (en) Base oil composition
NZ182022A (en) Antiglaucoma compositions comprising 1-t butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy)-2-prodanol hydogen maleate
JPS5299226A (en) Novel antiihypertension composition
PT65171B (en) Match-head compositions
JPS5232924A (en) Soluvent compositions
JPS5299227A (en) Novel antiihypertension composition
JPS5271552A (en) Compositions
JPS5299225A (en) Novel antiihypertension composition
GB1549356A (en) 3,4-dihydro-2h-1,3,5-oxadiazin-2-one derivatives